Qingnian Xu

2.6k total citations · 2 hit papers
22 papers, 1.8k citations indexed

About

Qingnian Xu is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Qingnian Xu has authored 22 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 6 papers in Infectious Diseases and 6 papers in Hepatology. Recurrent topics in Qingnian Xu's work include Liver Disease Diagnosis and Treatment (5 papers), COVID-19 Clinical Research Studies (5 papers) and Hepatitis B Virus Studies (5 papers). Qingnian Xu is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), COVID-19 Clinical Research Studies (5 papers) and Hepatitis B Virus Studies (5 papers). Qingnian Xu collaborates with scholars based in China, Australia and South Korea. Qingnian Xu's co-authors include Yun Ling, Zongguo Yang, Jun Chen, Li Liu, Yunfei Lu, Yinzhong Shen, Tao Li, Xiaorong Chen, Bozong Tang and Shuibao Xu and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and BioMed Research International.

In The Last Decade

Qingnian Xu

22 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical progression of patients with COVID-19 in Shanghai, China

2020 582 citations Jun Chen, Tangkai Qi et al. Journal of Infection profile →
[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].

2020 490 citations Jun Chen, Danping Liu et al. PubMed profile →

Peers

Countries citing papers authored by Qingnian Xu

Since Specialization

Citations

This map shows the geographic impact of Qingnian Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingnian Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingnian Xu more than expected).

Fields of papers citing papers by Qingnian Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingnian Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingnian Xu. The network helps show where Qingnian Xu may publish in the future.

Co-authorship network of co-authors of Qingnian Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Qingnian Xu. A scholar is included among the top collaborators of Qingnian Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingnian Xu. Qingnian Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk factors for myocardial injury at admission of 325 patients with coronavirus disease 2019 in Shanghai, China 2021 ·Australasian Journal on Ageing ·Mei Xue, Yuanyuan Ji, Zhiping Qian, Yun Ling, Hui Zhu, (unknown), Fang Shen, Qingnian Xu, Zhengguo Zhang, (unknown), Yu Liu, Hongying Guo, Ying Zou, Jiefei Wang, Yuyi Zhang, (unknown), Hongzhou Lu	2
2	Clinical progression of patients with COVID-19 in Shanghai, China breakdown → 2020 ·Journal of Infection ·Jun Chen, Tangkai Qi, Li Liu, Yun Ling, Zhiping Qian, Tao Li, Feng Li, Qingnian Xu, Yuyi Zhang, Shuibao Xu, Zhigang Song, Yigang Zeng, Yinzhong Shen, Yuxin Shi, Tongyu Zhu, Hongzhou Lu	582
3	[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19]. breakdown → 2020 ·PubMed ·Jun Chen, Danping Liu, Li Liu, Ping Liu, Qingnian Xu, Lu Xia, Yun Ling, Dan Huang, Shuli Song, Dandan Zhang, Zhiping Qian, Tao Li, Yinzhong Shen, Hongzhou Lu	490
4	Antiviral Activity and Safety of Darunavir/Cobicistat for the Treatment of COVID-19 2020 ·Open Forum Infectious Diseases ·Jun Chen, Lu Xia, Li Liu, Qingnian Xu, Yun Ling, Dan Huang, Wei Huang, Shuli Song, Shuibao Xu, Ying‐Zhong Shen, Hongzhou Lu	90
5	Predictors for imaging progression on chest CT from coronavirus disease 2019 (COVID-19) patients 2020 ·Aging ·Zongguo Yang, Jia Shi, (unknown), Ying Lü, Qingnian Xu, Chen Ye, (unknown), Bozong Tang, (unknown), Yunfei Lu, Xiaorong Chen	81
6	Traditional Chinese Medicine Formulation Therapy in the Treatment of Coronavirus Disease 2019 (COVID-19) 2020 ·The American Journal of Chinese Medicine ·Jia Shi, Yunfei Lu, Yuan Zhang, Lu Xia, Chen Ye, Ying Lü, Shishi Chen, Qingnian Xu, Bozong Tang, (unknown), Jing Zhang, Xiaorong Chen, Zongguo Yang	12
7	Add‐On Therapy with Traditional Chinese Medicine Improves Outcomes and Reduces Adverse Events in Hepatocellular Carcinoma: A Meta‐Analysis of Randomized Controlled Trials 2017 ·Evidence-based Complementary and Alternative Medicine ·Zongguo Yang, Xian Liao, Yunfei Lu, Qingnian Xu, Bozong Tang, Xiaorong Chen, Yongchun Yu	32
8	Moxibustion for Diarrhea‐Predominant Irritable Bowel Syndrome: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials 2016 ·Evidence-based Complementary and Alternative Medicine ·Bozong Tang, Jianliang Zhang, Zongguo Yang, Yunfei Lu, Qingnian Xu, Xiaorong Chen, (unknown)	29
9	Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis 2016 ·Oncotarget ·Zongguo Yang, Liping Zhuang, Yunfei Lu, Qingnian Xu, Bozong Tang, Xiaorong Chen	35
10	Upregulation of Heat Shock Proteins (HSPA12A, HSP90B1, HSPA4, HSPA5 and HSPA6) in Tumour Tissues Is Associated with Poor Outcomes from HBV-Related Early-Stage Hepatocellular Carcinoma 2015 ·International Journal of Medical Sciences ·Zongguo Yang, Liping Zhuang, Peter Szatmary, Wen Li, Hua Sun, Yunfei Lu, Qingnian Xu, Xiaorong Chen	138
11	HULC and H19 Played Different Roles in Overall and Disease-Free Survival from Hepatocellular Carcinoma after Curative Hepatectomy: A Preliminary Analysis from Gene Expression Omnibus 2015 ·Disease Markers ·Zongguo Yang, Yunfei Lu, Qingnian Xu, Bozong Tang, Cheol-Keun Park, Xiaorong Chen	65
12	Overexpression of APOBEC3F in tumor tissues is potentially predictive for poor recurrence-free survival from HBV-related hepatocellular carcinoma. 2015 ·PubMed ·Zongguo Yang, Liping Zhuang, Yu Yuan, (unknown), Yunfei Lu, Qingnian Xu, Bozong Tang, Xiaorong Chen	12
13	Aspartate aminotransferase-lymphocyte ratio index and systemic immune-inflammation index predict overall survival in HBV-related hepatocellular carcinoma patients after transcatheter arterial chemoembolization 2015 ·Oncotarget ·Zongguo Yang, Jianliang Zhang, Yunfei Lu, Qingnian Xu, Bozong Tang, Qiang Wang, Wensi Zhang, Shishi Chen, (unknown), Xiaorong Chen	61
14	Correlation of APOBEC3 in tumor tissues with clinico-pathological features and survival from hepatocellular carcinoma after curative hepatectomy. 2015 ·PubMed ·Zongguo Yang, Yunfei Lu, Qingnian Xu, Liping Zhuang, Bozong Tang, Xiaorong Chen	15
15	Effects and Tolerance of Silymarin (Milk Thistle) in Chronic Hepatitis C Virus Infection Patients: A Meta-Analysis of Randomized Controlled Trials 2014 ·BioMed Research International ·Zongguo Yang, Liping Zhuang, Yunfei Lu, Qingnian Xu, Xiaorong Chen	31
16	Efficacy and safety of peginterferon plus ribavirin for patients aged ≥ 65 years with chronic hepatitis C: A systematic review and meta-analysis 2013 ·Clinics and Research in Hepatology and Gastroenterology ·Zongguo Yang, Liping Zhuang, Lei Yang, Cheng Liu, Yunfei Lu, Qingnian Xu, Xiaorong Chen, Liang Chen	13
17	Clinical Features and Factors Associated with Outcomes of Patients Infected with a Novel Influenza A (H7N9) Virus: A Preliminary Study 2013 ·PLoS ONE ·Xiaorong Chen, Zongguo Yang, Yunfei Lu, Qingnian Xu, Qiang Wang, Liang Chen	18
18	Paeoniflorin regulates macrophage activation in dimethylnitrosamine-induced liver fibrosis in rats 2012 ·BMC Complementary and Alternative Medicine ·Xiaorong Chen, Cheng Liu, Yunfei Lu, Zongguo Yang, (unknown), Qingnian Xu, (unknown), (unknown)	30
19	Measles Virus Infection in Adults Induces Production of IL-10 and Is Associated with Increased CD4+CD25+ Regulatory T Cells 2008 ·The Journal of Immunology ·Xuelian Yu, Yu‐Ming Cheng, Bisheng Shi, (unknown), Feng‐Bin Wang, (unknown), (unknown), Qingnian Xu, Tangkai Qi, (unknown), Zhenghong Yuan, Reena Ghildyal	50
20	[Effect of moxibustion on immunological function in the patient of AIDS of spleen-kidney yang-deficiency]. 2007 ·PubMed ·Jiangrong Wang, (unknown), Qin Zhang, (unknown), Qingnian Xu, Hongzhou Lu	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact